Inventor · disambiguated record
Kwong-Yok Tsang
Also filed as: TSANG KWONG · TSANG KWONG Y · TSANG KWONG-YOK
43 granted patents·9 pending applications·563 citations·filing 1984–2024
98Inventor score
Top patents by PatentIndex Score
52 records- 0197US7314622B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersNEOGENIX ONCOLOGY INC·Filed 2006·Granted Jan 1, 2008·111 cites·8 claims
- 0296US7999071B2Human cytotoxic T-lymphoctye epitope and its agonist eptiope from the non-variable number of tandem repeat sequence of MUC-1US HEALTH·Filed 2004·Granted Aug 16, 2011·38 cites·45 claims
- 0395US10035832B2HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of useUS HEALTH·Filed 2014·Granted Jul 31, 2018·19 cites·6 claims
- 0495US7247615B2Peptide agonists of prostate-specific antigen and uses thereforUS HEALTH·Filed 2002·Granted Jul 24, 2007·74 cites·23 claims
- 0594US9175057B2Immunogenic peptides and methods of useSCHLOM JEFFREY·Filed 2011·Granted Nov 3, 2015·18 cites·36 claims
- 0693US11155588B2HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of useTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2019·Granted Oct 26, 2021·3 cites·7 claims
- 0793US7547773B2Nucleic acid molecules encoding prostate specific antigen oligo epitope peptidesUS HEALTH·Filed 2006·Granted Jun 16, 2009·9 cites·35 claims
- 0891US7763720B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersNEOGENIX ONCOLOGY INC·Filed 2007·Granted Jul 27, 2010·18 cites·29 claims
- 0989US12325731B2HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of useTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2023·Granted Jun 10, 2025·0 cites·10 claims
- 1089US10188714B2Yeast-MUC1 immunotherapeutic compositions and uses thereofGLOBEIMMUNE INC·Filed 2016·Granted Jan 29, 2019·6 cites·22 claims
- 1189US9034588B2Monoclonal antibody therapy for pancreas cancerARLEN MYRON·Filed 2011·Granted May 19, 2015·11 cites·19 claims
- 1289US8470326B2Monoclonal antibody therapy for pancreas cancerARLEN MYRON·Filed 2011·Granted Jun 25, 2013·11 cites·19 claims
- 1389US7871986B2Methods of stimulating an immune response against prostate specific antigenUS HEALTH·Filed 2009·Granted Jan 18, 2011·4 cites·38 claims
- 1488US9605077B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2015·Granted Mar 28, 2017·5 cites·18 claims
- 1588US8535667B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersARLEN MYRON·Filed 2010·Granted Sep 17, 2013·8 cites·11 claims
- 1688US7910692B2Immunogenic peptides and methods of useUS HEALTH·Filed 2007·Granted Mar 22, 2011·7 cites·39 claims
- 1788US5688657AMonoclonal antibodies against human colon carcinoma-associated antigens and uses thereforINT BIO IMMUNE SYSTEMS INC·Filed 1994·Granted Nov 18, 1997·91 cites·50 claims
- 1887US9169326B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersARLEN MYRON·Filed 2011·Granted Oct 27, 2015·7 cites·16 claims
- 1987US8178508B2Methods of stimulating an immune response against prostate specific antigenSCHLOM JEFFREY·Filed 2010·Granted May 15, 2012·3 cites·18 claims
- 2086US6946133B1Prostate specific antigen oligo-epitope peptideUS HEALTH·Filed 1996·Granted Sep 20, 2005·55 cites·16 claims
- 2185US12460013B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2022·Granted Nov 4, 2025·0 cites·12 claims
- 2285US11001641B2Monoclonal antibody therapy for pancreas cancerPREC BIOLOGICS INC·Filed 2018·Granted May 11, 2021·1 cites·19 claims
- 2385US10508141B2Nucleic acids encoding HLA-A24 agonist epitopes of MUC1-C oncoproteinUS HEALTH·Filed 2018·Granted Dec 17, 2019·2 cites·21 claims
- 2485US10364295B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2017·Granted Jul 30, 2019·3 cites·19 claims
- 2585US9592290B2Monoclonal antibody therapy for pancreas cancerPREC BIOLOGICS INC·Filed 2014·Granted Mar 14, 2017·5 cites·11 claims
- 2684US11572413B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2019·Granted Feb 7, 2023·1 cites·14 claims
- 2784US8188214B2Brachyury polypeptides and methods for useSCHLOM JEFFREY·Filed 2008·Granted May 29, 2012·6 cites·42 claims
- 2882US8613933B2Brachyury polypeptides and methods for useSCHLOM JEFFREY·Filed 2012·Granted Dec 24, 2013·5 cites·29 claims
- 2979US8748390B2Immunogenic epitopes of NGEP antigenSCHLOM JEFFREY·Filed 2010·Granted Jun 10, 2014·1 cites·24 claims
- 3079USRE39760EMonoclonal antibodies against human colon carcinoma-associated antigens and uses thereforINTERNAT BIO IMMUNE SYSTEMS IN·Filed 2000·Granted Aug 7, 2007·22 cites·50 claims
- 3178US10138271B2Native and agonist CTL epitopes of the MUC1 tumor antigenUS HEALTH·Filed 2013·Granted Nov 27, 2018·3 cites·25 claims
- 3277US11767367B2Monoclonal antibody neo-201 for the treatment of human carcinomasPREC BIOLOGICS INC·Filed 2018·Granted Sep 26, 2023·1 cites·19 claims
- 3377US11732017B2HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of useTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2021·Granted Aug 22, 2023·0 cites·6 claims
- 3477US9533031B2Yeast-MUC1 immunotherapeutic compositions and uses thereofGLOBEIMMUNE INC·Filed 2013·Granted Jan 3, 2017·2 cites·24 claims
- 3573US2024101702A1Monoclonal antibody neo-201 for the treatment of human carcinomasPREC BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 3672US11065318B2Yeast-MUC1 immunotherapeutic compositions and uses thereofGLOBEIMMUNE INC·Filed 2018·Granted Jul 20, 2021·0 cites·12 claims
- 3772US8933041B2System for treating and preventing breast cancerPANICALI DENNIS L·Filed 2004·Granted Jan 13, 2015·3 cites·27 claims
- 3871US2024400714A1Methods and compositions for targeting treg cellsPREC BIOLOGICS INC·Filed 2024·Application pending·0 cites
- 3967US9370559B2Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1US HEALTH·Filed 2013·Granted Jun 21, 2016·0 cites·12 claims
- 4062US11311613B2Development of agonist epitopes of the human papillomavirusUS HEALTH·Filed 2017·Granted Apr 26, 2022·0 cites·25 claims
- 4161US8957192B2Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1SCHLOM JEFFREY·Filed 2011·Granted Feb 17, 2015·0 cites·22 claims
- 4260US8901093B2Custom vectors for treating and preventing pancreatic cancerPANICALI DENNIS L·Filed 2004·Granted Dec 2, 2014·1 cites·24 claims
- 4360US7491801B2Identification and development of specific monoclonal antibodies to squamous cell carcinomaINTERNAT BIOIMMUNE SYSTEMS INC·Filed 2001·Granted Feb 17, 2009·2 cites·7 claims
- 4460US2014135488A1Brachyury polypeptides and methods for useUS HEALTH·Filed 2013·Application pending·0 cites
- 4559US2005196806A1Prostate specific antigen oligoepitope peptideUS GOV HEALTH & HUMAN SERV·Filed 2005·Application pending·0 cites
- 4659US2006228363A1Monoclonal antibody therapy for pancreas cancerARLEN MYRON·Filed 2005·Application pending·0 cites
- 4759US2017210816A1Monoclonal antibody therapy for pancreas cancerPREC BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 4858US12037410B2Methods and compositions for targeting Treg cellsPREC BIOLOGICS INC·Filed 2019·Granted Jul 16, 2024·0 cites·12 claims
- 4958US2014287029A1Immunogenic epitopes of ngep antigenUS HEALTH·Filed 2014·Application pending·0 cites
- 5053US2024384003A1Methods and compositions for treating hematological malignanciesPREC BIOLOGICS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kwong-Yok Tsang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →